Jeffrey G. Lamothe

CIK: 0001679967

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (80.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

APVO

Aptevo Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

APVO
Aptevo Therapeutics Inc.
Aug 6, 2026
Exercise(M)
Direct
961 shares-
APVO
Aptevo Therapeutics Inc.
Aug 6, 2025
Award(A)
Restricted Stock Unit
Direct
17.3K shares-
APVO
Aptevo Therapeutics Inc.
Jul 17, 2025
Exercise(M)
Direct
5 shares-
APVO
Aptevo Therapeutics Inc.
Mar 3, 2025
Exercise(M)
Direct
2 shares-
APVO
Aptevo Therapeutics Inc.
Mar 2, 2025
Exercise(M)
Direct
3 shares-

		Type	Shares	Price		Ownership
Aug 6, 2026	APVO Aptevo Therapeutics Inc.	Exercise(M)	961	-	$0	Direct
Aug 6, 2025	APVO Aptevo Therapeutics Inc.	Award(A) Restricted Stock Unit	17,300	-	-	Direct
Jul 17, 2025	APVO Aptevo Therapeutics Inc.	Exercise(M)	5	-	-	Direct
Mar 3, 2025	APVO Aptevo Therapeutics Inc.	Exercise(M)	2	-	-	Direct
Mar 2, 2025	APVO Aptevo Therapeutics Inc.	Exercise(M)	3	-	-	Direct

1-5 of 5 transactions

About Lamothe Jeffrey G.

Lamothe Jeffrey G. (SEC CIK 0001679967) files insider reports with the SEC as President and CEO of Aptevo Therapeutics Inc. (APVO).

Signal8 holds 4 ownership filings by Lamothe Jeffrey G., all Form 4s, filed between Mar 4, 2025 and Aug 10, 2026. Those filings report 5 transactions, from Mar 2, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lamothe Jeffrey G.'s filings is in SEATTLE, WA.

Recent filings by Lamothe Jeffrey G.

Aug 6, 2026: Option exercise of APVO shares (Form 4, code M).
Aug 6, 2025: Grant or award of APVO derivative securities (Form 4, code A).
Jul 17, 2025: Option exercise of APVO shares (Form 4, code M).
Mar 3, 2025: Option exercise of APVO shares (Form 4, code M).
Mar 2, 2025: Option exercise of APVO shares (Form 4, code M).

Other insiders filing for Aptevo Therapeutics Inc. (APVO)

Harsanyi Zsolt, Director
Taylor Daphne, SVP, CFO
Kwon SoYoung, SVP, GC, BD & Corp Affairs
Huebner Dirk, SVP, CMO
Grant Grady III, Director
White Marvin L, Executive Chair

How to read Form 4 transaction codes